Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Dec 23 2021

Full Issue

AstraZeneca Booster Effective Against Omicron; Sinovac's 3 Doses Aren't

Oxford scientists, Reuters reports, have found that a booster shot (completing a 3-dose course) of AstraZeneca's covid shot tackles omicron variant covid. But Bloomberg reports on research showing a 3-dose course of China's Sinovac vaccine doesn't produce enough antibodies to combat omicron.

Reuters: AstraZeneca Vaccine Booster Works Against Omicron, Oxford Lab Study Finds 

A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study. (Aripaka, 12/23)

Bloomberg: Sinovac Vaccine Efficacy: Three Doses Fail To Protect Against Omicron In Study

Two doses and a booster of the Covid-19 vaccine made by China’s Sinovac Biotech Ltd., one of the most widely used in the world, didn’t produce sufficient levels of neutralizing antibodies to protect against the omicron variant, a laboratory study found. The research suggests that people who’ve received Sinovac’s shot, known as CoronaVac, should seek out a different vaccine for their booster: Getting Germany’s BioNTech SE’s messenger RNA as a third dose saw those previously fully vaccinated with CoronaVac significantly improve in protective levels of antibodies against omicron, according to the study from the University of Hong Kong and The Chinese University of Hong Kong. (Hong, 12/23)

Reuters: France Cancels Order For Merck's COVID-19 Antiviral Drug 

France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer's competing drug before the end of January, the health minister said on Wednesday. (Spencer and Parodi, 12/22)

NBC News: Puerto Rico's High Vaccination Rates Help Minimize Hospitalizations Amid Surge

Two months ago, Puerto Rico led all states and U.S. territories in Covid-19 prevention and vaccination rates among adults and children. Now, with the rise of the omicron variant, Puerto Rico remains among the top three U.S. jurisdictions (alongside Vermont and Guam) with the highest rates of Covid-19 vaccinations, according to NBC News’ vaccination tracker. (Acevedo, 12/22)

In news about the Beijing Winter Olympics —

AP: China Puts 13 Million Residents In Lockdown Ahead Of Games 

China is redoubling efforts to control new virus outbreaks with a lockdown of the 13 million residents of the northern city of Xi’an following a spike in coronavirus cases. The measure comes just weeks before the country hosts the Winter Olympics in Beijing, roughly 1,000 kilometers (6210 miles) to the west. (12/23)

Reuters: Winter Olympics: China Expects COVID Cases Due To Games Arrivals, Flags Omicron Risk

Organisers of the Beijing Winter Olympics said on Thursday they expect a "certain number" of COVID-19 cases in China due to foreigners arriving for the Games, and strongly urged participants to get vaccination boosters due to the spread of the Omicron variant. Officials also sought to alleviate concerns about health care for participants prompted by COVID as well as an accident last month in a luge training session at the Beijing venue during which a Polish slider suffered a severe leg injury. (Tian, 12/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF